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Abstract
A case of 77-year-old female with an invasive lobular carcinoma with extracellular mucin 
is presented. She felt palpable mass in her left breast. Then, she came to our hospital for 
further examination. Mammography of right in full view revealed architectural distortion 
in left upper portion. And ultrasonography demonstrated low-echoic mass about 2 cm in 
diameter and invasion of the fat tissue was observed. Hence, malignancy was suspected and 
magnetic resonance imaging (MRI) was performed. MRI findings showed irregular shaped 
and margined mass with small T2-high-signal intensity. These findings suggested invasive 
carcinoma with mucin. Because the cancer lesion was not large, partial mastectomy was per-
formed. Interestingly, pathological diagnosis was invasive lobular carcinoma with extracellu-
lar mucin. Extracellular mucinous lesion was concordant with small T2-high-signal intensity. 
This type of carcinoma was previously reported only in three cases, and rare but important, 
because the treatment and prognosis might change by histological subtypes. We suggest one 
of the MRI special features of our case is not only irregular shaped and margined mass but 
also small T2-high-signal intensity. These MR findings might be one of the valuable findings 
for the diagnosis and differentiation between this type of carcinoma from other tumors.
Keywords: magnetic resonance imaging, breast, invasive lobular carcinoma, extracellular 
mucin, E-cadherin
1. Introduction
To discriminate between invasive lobular carcinoma and invasive ductal carcinoma is a big 
theme for both radiologically and pathologically. The limitation of radiologic imaging in the 
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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detection and evaluation of invasive lobular carcinoma have been recognized for a long time. 
Whereas, advances in breast radiologic imaging present opportunities to improve the diagno-
sis of invasive lobular carcinoma.
On mammography, invasive lobular carcinoma is not likely to form calcifications. However, 
calcifications may be present in benign proliferative lesions such as sclerosing adenosis [1]. 
The most common manifestations of invasive lobular carcinoma are asymmetric density, 
irregular, or spiculated mass on mammography [2–4].
On ultrasonography, 60.5% of invasive lobular carcinomas produced “a heterogeneous 
low-echoic mass with angular or irregular margins and posterior acoustic shadowing.” The 
remaining tumors had various other sonographic characteristics, including 12% that were 
“ultrasonographically invisible.” The sensitivity of ultrasonography for tumors measuring 
less than 1 cm was 85.7%. Invasive lobular carcinoma of common type tended to produce 
“focal shadowing without a discrete mass,” whereas tumors with pleomorphic histology 
were seen as “a shadowing mass.” Tumors of the alveolar, solid, and signet-ring variant of 
invasive lobular carcinoma were most often manifested as a “lobulated, well circumscribed 
mass” [5]. Ultrasonography is useful and more accurate than mammography in diagnos-
ing invasive lobular carcinoma [5]. However, it is difficult to narrow down the diagnosis of 
invasive lobular carcinoma.
Breast magnetic resonance imaging (MRI) has an overall sensitivity of 93% for detect-
ing invasive lobular carcinoma, similar to the detection of breast cancers overall (90%). 
On MRI, tumor of smooth margin, or absence of smooth margin and the distribution 
of nonmass-like enhancement are the features of invasive lobular carcinoma. Invasive 
lobular carcinoma may present as ductal, segmental, regional, or diffuse patterns [6]. 
MR imaging is considered to be a useful tool for detecting invasive lobular carcinoma on 
radiologically.
Pathologically, the invasive lobular carcinoma includes not only classical type (Foote and 
Stewart advocated in 1946 [7]) but also variants of solid, alveolar, pleomorphic, tubulolobular, 
signet-ring, trabecular, and mixed types [8].
We encountered a tumor of invasive carcinoma coexisting with mucinous carcinoma-like 
lesion. At first, the differential diagnoses of this tumor are (i) mixed mucinous-ductal carci-
noma, (ii) mucinous carcinoma with neuroendocrine feature, (iii) mucinous papillary neo-
plasms, and (iv) carcinoma of mixed type (lobular and ductal carcinoma). Lobular carcinoma 
has been considered a variant of mucin-secreting carcinoma with only intracytoplasmic 
mucin [9–11]. In common practice, a diagnosis of mucinous carcinoma or ductal carcinoma 
with mucinous features is often made in the presence of extracellular mucin, without immu-
nohistochemical confirmation of the ductal phenotype [10]. However, final diagnosis was 
“invasive lobular carcinoma with extracellular mucin” which has been reported only in three 
cases in the English medical literature [9–11]. Accordingly, the current report is the fourth 
documented case in pathology, and in the viewpoint of radiology, this is the first case.
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Taking into consideration of the above information, we will discuss the unique variant of 
“invasive lobular carcinoma with extracellular mucin” with radiopathological correlation.
2. Materials and methods
2.1. MR imaging protocol
MR imaging was performed using a 1.5T MR system (Achieva 1.5T, Philips Healthcare Nederland, 
Eindhoven, Netherland), and a synergy breast coil. Routine breast MR images were acquired as 
follows in the prone position: axial T2-weighted turbo spin echo (TSE) with STIR images (repeti-
tion time (TR)/echo time (TE) = 5175/60 ms, section thickness = 5 mm, FOV = 280 mm, matrix = 
480 × 480), and axial diffusion-weighted (DW) images using a single-shot EPI (FOV = 280 mm, 
matrix = 128 × 128), with MPG pulse applied along three directions (x, y, and z axes) with TR/TE 
of 5532/80 ms and b-factors of 0, 1000, and 2000 s/mm2. Apparent diffusion coefficient (ADC)-
maps were automatically generated on a postprocessing workstation. After axial T1-weighted 
SE images, [TR/TE = 468.8/12 ms, flip angle = 90, section thickness = 5 mm, FOV = 280 mm, 
matrix = 128 × 128] were obtained, axial 3D dynamic contrast enhanced T1-weighted images 
with SPAIR using eTHRIVE sequence [TR/TE = 5.9/2.8 ms, flip angle = 10, section thickness = 5 
mm, FOV = 280 mm, matrix = 512 × 512] were performed in precontrast, double arterial phase, 
and delayed phase.
2.2. Image interpretation
For image interpretation of mammography, ultrasonography, and magnetic resonance imag-
ing, we used the breast imaging and reporting data system (BI-RADS) lexicon and associated 
report of Tozaki et al. [12, 13].
2.3. Hematoxylin and eosin staining
Operation samples obtained from the partial mastectomy were fixed at least 8 h in 10% neu-
tral phosphate buffered formalin, then, embedded in paraffin, and sectioned at 3–4 μm. The 
paraffin-embedded specimens were stained with hematoxylin and eosin (HE) for light micro-
scopic examination.
2.4. Immunohistochemistry
Paraffin-embedded sections measuring 3–4 μm thick were deparaffinized. Antigen retrieval 
was then performed for 20–40 min in boiling water (95°C) containing citric acid solution (pH 
6.0) or Target Retrieval Solution (pH 9.0; cat. no. 415211; Nichirei, Tokyo, Japan), and (pH 6.0; 
cat. no. S2031; Dako, Glostrup, Denmark). Sections were pretreated with 0.3% peroxide and 
reacted with primary monoclonal antibodies against estrogen receptor (ER), progesterone 
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receptor (PgR), HER2, Ki67, E-cadherin, Synaptophysin, MUC1, and MUC3 are shown in 
Table 1. Subsequently, specimens were incubated with a secondary antibody (Histofine sim-
ple stain MAX-PO; cat. no. 424154; Nichirei). The chromogenic substrate was 3,3′-diamino-
benzidine (DAB), and the slides were counterstained with hematoxylin.
3. Results
A case of 77-year-old female is presented. She felt palpable mass in her left breast since 1 
month and came to our hospital for further examination.
Physical examination revealed a 2.7 cm palpable mass in left upper inner and outer quadrants 
without nipple discharge and lymphadenopathy. No familial history of breast cancer was 
confirmed.
On mammography, the breast appeared dense. However, mediolateral oblique (MLO) view 
of the mammography demonstrated architectural distortion in left upper portion (Figure 1). 
Hence, this lesion was of four categories. Right MLO view revealed no evidence of malignancy.
Ultrasonography revealed a low-echoic mass about 2 cm in diameter with posterior acoustic 
shadowing, and disruption of the anterior border line (the anterior border line means bound-
ary line between fat tissue layer and breast parenchymal layer) of the mass was observed in 
her left breast (Figure 2). There was no lesion suggesting malignancy in her right breast. No 
lymph node swelling was seen.
These findings suggested the possibility of malignancy. Therefore, magnetic resonance 
imaging (MRI) of 1.5T (Philips) was performed. On MRI, diffusion-weighted image of 
b-value 1000 s/mm2 showed mass-like lesion with high signal intensity (Figure 3A). 
Apparent diffusion coefficient (ADC)-map revealed diffusion limitation of the water mol-
ecule (Figure 3B). Dynamic contrast-enhanced T1 weighted images demonstrated early 
enhancement and delayed washout pattern of irregular shaped and margined mass about 
Antibody Clone Source Activation Dilution
ER EP1 DAKO Heat pH 9.0/40 min 1:2
PgR PgR636 DAKO Heat pH 6.0/40 min 1:2
HER2 Rabbit poly DAKO Heat pH 6.0/40 min 1:1
Ki-67 MIB-1 DAKO Heat pH 6.0/40 min 1:200
E-cadherin 35B5 Leica Heat pH 6.0/40 min 1:2
Synaptophysin 27G12 NICHIREI Heat pH 9.0/40 min 1:2
MUC1 Ma552 Leica Heat pH 6.0/40 min 1:100
MUC3 1143/B7 Lab Vision Heat pH 6.0/40 min 1:100
Table 1. Primary monoclonal antibodies against ER, PgR, HER2, Ki67, E-cadherin, synaptophysin, MUC1, and MUC3.
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2 cm in diameter (Figure 3C and D). The mass included a small high signal intensity area 
on fat-saturated T2 weighted image, which was confirmed pathologically as extracellular 
mucin. (Figure 3E). Dynamic-curve of the contrast-enhanced MRI showed rapid wash-
out pattern (Figure 3F). ADC value was 0.577 × 10−3 mm2/s; hence, the existence of water 
restriction was suggested.
Neoadjuvant chemotherapy was not performed. Then, partial mastectomy was performed 
because of the imaging findings. Sentinel lymph node was negative for metastatic cancer 
lesion. Further, axillary lymph node resection was not performed. Histopathological find-
ings revealed low-grade tumor with little or no nuclear atypia and inconspicuous nucleoli. 
Besides, the tumor was composed of single cell with moderate pleomorphism and lack of 
cohesion. The neoplastic cells were arranged in files or cords infiltrating the stroma. Partially, 
trabecular type lesion was observed (Figure 4A). Within the tumor, there were areas show-
ing signet-ring cells floating in a pool of mucin (Figure 4B). The presence of the extracellular 
mucin is not a characteristic of lobular carcinomas. Therefore, immunohistochemical stain for 
E-cadherin was performed. However, the lesions were negative for E-cadherin immunostain-
ing (Figure 4C). Besides, neuroendocrine marker of synaptophysin was completely negative. 
MIB1 (Ki67)-index was about 10%. Estrogen receptor (ER), progesterone receptor (PgR), and 
human epidermal growth factor receptor 2 (HER2) status were 99, 0%, and negative, respec-
tively. Additionally, special stainings for mucin as MUC1 and MUC3 were performed, and 
both stainings were positive of both infiltrating cells and signet-ring cells floating in a pool of 
mucin (Figure 4D and E).
Figure 1. MLO view of the mammography demonstrates architectural distortion in left upper portion (arrow).
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Figure 3. (A) Diffusion-weighted image of b-1000 shows mass like high signal intensity. (B) Apparent diffusion 
coefficient (ADC)-map reveals diffusion limitation of the water molecule. (C) Contrast-enhanced T1 weighted images 
demonstrate early enhancement and (D) delayed washout pattern. (E) The mass included a small high-signal intensity 
on fat-saturated T2 weighted image, which is confirmed pathologically as extracellular mucin (arrow). (F) Dynamic-
curve of the MRI shows rapid washout pattern.
Figure 2. Ultrasonography reveals a low-echoic mass, posterior acoustic shadowing, and disruption of the anterior 
border line is observed.
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4. Discussion
The major types of invasive carcinomas are categorized as ductal carcinoma. Invasive lobular 
carcinoma is the second most common histological type of breast carcinoma, accounting for 
about 5–15% of all invasive breast cancers [14, 15]. Hence, accurate diagnosis of invasive lobu-
lar carcinoma is thought to be important. We will discuss about general radiological findings 
of invasive lobular carcinoma and correlation of our case.
In mammography, Berg et al. [16] examined the performance of mammography as a func-
tion of both tumor type and breast density. Mammographic sensitivity was 81% for inva-
sive ductal carcinoma compared with 34% for invasive lobular carcinoma; when only those 
patients with dense breast tissue were considered, sensitivities decreased dramatically to 
60 and 11%, respectively [16]. Because of these diagnostic interests, it is crucial for breast 
radiologists to be aware of the asymmetric and subtle mammographic features of invasive 
lobular carcinoma.
A high-density spiculated or irregular margined mass on mammography means invasive car-
cinoma. Spicula or irregular margin is thought to be invasion of the breast fat tissue and stro-
mal reaction that disrupts normal breast parenchymal architecture. common mammographic 
manifestations of invasive lobular carcinoma include spiculated or irregular margined mass 
or asymmetric density. In our case, these findings are not observed. Apart from spiculated, 
irregular margined masses and asymmetric densities, the most common mammographic 
manifestation of invasive lobular carcinoma is architectural distortion, which accounts for 
about 14–25% of cases of mammographically detected invasive lobular carcinoma [3, 17, 18]. 
Figure 4. (A) The neoplastic cells are arranged in files or cords infiltrating the stroma. Partially, trabecular type lesion is 
observed. (B) Within the tumor, there are areas showing atypical cells floating in a pool of mucin. (C) All the tumor cells 
are negative for E-cadherin immunostaining. (D) All the tumor cells and extracellular mucin are MUC1 positive. (E) All 
the tumor cells and extracellular mucin are MUC3 positive.
A Case of an Invasive Lobular Carcinoma with Extracellular Mucin: Radio-Pathological Correlation
http://dx.doi.org/10.5772/intechopen.69389
7
Similarly, our case demonstrated architectural distortion on left upper portion in MLO view. 
We think distortion on mammography means stromal reaction and malignancy.
Ultrasonography of the breast is used primarily as a diagnostic imaging tool. The most 
common sonographic appearance of invasive lobular carcinoma is a low-echoic mass with 
posterior acoustic shadowing occurring in up to 60% of cases, however, posterior acoustic 
shadowing may be lacking in up to 20% of cases [19]. The present case of ultrasonographical 
findings is thought to be concordant with report of Karen et al. [19].
Here, we will discuss correlation between MRI findings and pathological findings. Our case 
of mammographic and ultrasonographic findings suggested the possibility of malignancy. 
Therefore, magnetic resonance imaging (MRI) of 1.5T (Philips) was performed. On MRI, diffu-
sion-weighted image of b-value 1000 s/mm2 showed mass-like high signal intensity. Apparent 
diffusion coefficient (ADC)-map revealed diffusion limitation of the water molecule. Besides, 
irregular shaped and margined mass was observed in T1 weighted image. These findings sug-
gest malignancy in our case. Furthermore, this finding is similar to the report of Mann et al. 
of invasive lobular carcinoma [6]. Fat-saturated T2 weighted image of the mass showed small 
high signal intensity area within the mass. This finding suggests the tumor associated muci-
nous lesion or coexistence of mucinous carcinoma. However, Rosa et al. [9] reported signet-
ring cells floating in a pool of mucinous areas (extracellular mucinous lesion) represented at 
the most 20% of the tumor. We think this extracellular mucin area is not so large but a small 
area. If invasive carcinoma and mucinous carcinoma are coexisted as collision tumor, the 
mucinous area which shows very high signal intensity on T2 weighted image would be larger. 
In our case, extracellular mucin area was approximately 10% of the tumor. This small area of 
high signal intensity on T2 weighted image might be one of the specific features of invasive 
lobular carcinoma with extracellular mucin. Dynamic-curve of the contrast-enhanced MRI 
showed rapid washout pattern. Rapid washout pattern is also seen in invasive ductal or lobu-
lar carcinoma. ADC value was 0.577 × 10−3 mm2/s, hence the existence of water restriction was 
suggested. From these findings, dynamic-curve, diffusion-weighted image, and ADC-map 
were suggestive for malignant tumor. And contrast-enhanced T1 weighted image of irregular 
shaped and margined mass was indicative of invasive carcinoma such as invasive ductal car-
cinoma or invasive lobular carcinoma. T2 weighted image of small high signal intensity area 
is thought to be mucinous carcinoma or mucin production. And mucin production is known 
to be associated with neuroendocrine differentiation. Taking these findings into consider-
ation, other differential diagnoses of this tumor were (i) mixed mucinous-ductal carcinoma, 
(ii) mucinous carcinoma with neuroendocrine feature, (iii) mucinous papillary neoplasms, 
and (iv) carcinoma of mixed type (lobular and ductal carcinoma). However, histopathological 
findings revealed the tumor was composed of single cell with moderate pleomorphism and 
lack of cohesion. The neoplastic cells were arranged in files or cords infiltrating the stroma. 
In situ lesion of the invasive lobular carcinoma was not observed. The multifocality of cancer 
lesion was not demonstrated. Within the tumor, there were areas showing signet-ring cells 
floating in a pool of mucin. The presence of extracellular mucin is not characteristic of lobular 
carcinomas. Therefore, immunohistochemical stain for E-cadherin was performed. However, 
the lesions were completely negative for E-cadherin immunostaining. E-cadherin, a cell-cohe-
sion protein encoded by a gene on chromosome 16q22.1, is the current marker of choice to 
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help discriminate between lobular and ductal carcinoma [11]. Neuroendocrine marker of syn-
aptophysin immunostaining was also negative. Hence, final diagnosis of our tumor is inva-
sive ductal carcinoma with extracellular mucin. From the results of MRI findings, irregular 
shaped and margined mass with small area of fat-saturated T2 high signal intensity might be 
one of the special feature of invasive lobular carcinoma with extracellular mucin. Our case is 
the fourth case in the English literature. Because the number of cases of these tumors is lim-
ited, it is difficult to comment on the biological behavior and molecular profiles. However, this 
diagnosis is important for prognosis and management, and further examination is needed.
In our case, estrogen receptor (ER), progesterone receptor (PgR), and human epidermal 
growth factor receptor 2 (HER2) status were 99, 0%, and negative, respectively. Invasive lobu-
lar carcinoma is known to be more commonly estrogen receptor-positive and HER2-negative, 
in other words, invasive lobular carcinoma is usually categorized as luminal subtype. The 
previous reports of Rosa et al. and Haltas et al. [9, 11] are ER positive of luminal subtype. 
Our case is concordant with their results. However, the results of Yu et al. [10] were not only 
ER-positive but also HER2 strongly positive. They thought that this type of HER2 status dem-
onstrate various features.
The spectrum of breast lesions that demonstrate extracellular mucin includes fibrocystic 
change with luminal mucin, mucocele-like lesions, papillary lesions with mucin secretion, 
and mucinous carcinoma among others [9]. In contrast, lobular neoplasia and invasive lobu-
lar carcinoma demonstrate intracytoplasmic mucin, and no cases of lobular carcinoma with 
extracellular mucin have been found except previous three reports [9–11, 20].
Invasive lobular carcinoma comprises 5–15% of invasive breast tumors [14, 15]. They can occur 
at any age. The median age at diagnosis is between 45 and 56 years and there is a tendency 
to affect older patients compared with ductal carcinoma [8, 9], similar to our results of the 
77-year-old. The presenting symptom in most cases is a mass with irregular margins or a breast 
thickening with diffuse nodularity [8, 9]. The clinical features of invasive lobular carcinoma are 
also different from that of ductal carcinomas. Invasive lobular carcinomas tend to be more often 
multifocal and bilateral [8, 9], with a distinct metastatic pattern and a higher frequency of bone, 
gastrointestinal tract, uterus, meninges, and diffuse serosal involvement [21]. Hence, discrimi-
nation between lobular carcinoma and ductal carcinoma is important clinically, radiologically, 
and pathologically. In our case, multifocality of the tumor was not observed similarly to the 
reports of Rosa et al. and Yu et al. [9, 10]. However, the case of Haltas et al. [11] indicated mul-
tifocality. We think this is because the variant of invasive lobular carcinoma with extracellular 
mucin might present different behavior compared with classical invasive lobular carcinoma.
Mucin has been classified as membrane-bound mucin, which mediates signal transduction, 
and secretary mucin, which are directly secreted into extracellular spaces. In the MUC immu-
nostaining family, the membrane-bound mucins include MUC1, MUC3, MUC4, and the sec-
retary mucins include MUC2, MUC5AC, MUC6 [22]. In our current case, MUC4, MUC5AC, 
and MUC6 were negative; however, all the tumor cells revealed cytoplasmic expression of 
MUC1. Molecular and biochemical studies have demonstrated that MUC1 is involved in the 
inhibition of E-cadherin mediated -cell and cell-matrix adhesion [10, 22–25]. The cytoplasmic 
domain of MUC1 molecule has been shown to inhibit the formation of E-cadherin-β-catenin 
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complex [10, 24]. Therefore MUC1 may play a role in tumor invasion and metastases by 
disrupting cell adhesions [10]. Similarly, our case of tumor invasion may correlate with the 
MUC1 cytoplasmic expression.
Additionally, our case of all the tumor cells was positive for MUC3 immunostaining. Rakha et 
al. and Furuya et al. [26, 27] reported that MUC3 immunostaining is useful for distinguishing 
between benign lesion and malignant lesion of the breast carcinoma. Our case is concordant 
with their reports, and membrane-bound mucin of MUC3 may mediate signal transduction 
correlate with malignancy. Furthermore, Rakha et al. [26] indicated that most breast carcino-
mas express MUC1, MUC3, and MUC4; however, MUC1 and MUC3 are potential prognostic 
indicators. Hence, diagnosing invasive lobular carcinoma with extracellular mucin is impor-
tant on not only pathologically but also radiologically.
Early genomic studies revealed very little overall difference in genomic profiles between 
low-grade invasive ductal carcinoma and classical invasive lobular carcinoma, implying that 
classical invasive lobular carcinoma might represent a subtype of low-grade invasive ductal 
carcinoma [10]. Recent gene expression studies comparing invasive lobular carcinoma and 
invasive ductal carcinoma have identified two subsets of invasive lobular carcinoma with 
distinct transcription patterns [10]. Approximately, half of the invasive lobular carcinomas 
differs from invasive ductal carcinomas in gene expression profiles (“typical” invasive lobu-
lar carcinomas), while the remaining invasive lobular carcinomas closely resemble invasive 
ductal carcinomas in transcription patterns. (“ductal-like” invasive lobular carcinomas) [10]. 
On the other hand, a recent study on grade- and molecular subtype-matched invasive lobular 
carcinomas and invasive ductal carcinomas of no special type demonstrated that invasive 
lobular carcinomas had different transcriptomic profiles in the genes related to cell-to-cell 
adhesion and signaling, as well as actin cytoskeleton signaling, when compared with grade- 
and molecular subtype-matched invasive ductal carcinomas [10]. This finding suggested that 
even though invasive lobular carcinomas and invasive ductal carcinomas might present as a 
spectrum or form of a family [10]. Taking into consideration of the above Yu et al. reported 
case, our current case might be in the middle stage of the spectrum between lobular carci-
noma and ductal carcinoma. We think existence of extracellular mucin is not definitive for 
ductal phenotype not only histologically but also genetically.
5. Conclusion
We encountered the distinct variant of invasive lobular carcinoma with extracellular mucin. 
We described the correlation of its radiological and pathological interest. Radiological find-
ings of invasive lobular carcinoma with extracellular mucin are documented in English lit-
erature for the first time. We suggest one of the MRI special features of our case is not only 
irregular shaped and margined mass but also small T2-high-signal intensity. These findings 
by the knowledge from radiopathological correlation might be one of the specific features 
of invasive lobular carcinoma with extracellular mucin. Further examinations are needed to 
clarify this lesion.
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